MetRes to acquire mothballed Australian coal mines from Peabody Energy

The MetRes joint venture (JV) between Stanmore Coal and M Resources has agreed to acquire the Millennium and Mavis Downs coal mines in Australia from Peabody Energy.

The JV signed an agreement to purchase the mines, which are currently in care and maintenance, for an upfront cash consideration of nearly $1m (A$1.25m) and a royalty agreement, which is capped at $1m (A$1.25m).

Regis Resources to acquire stake in Tropicana gold project for $688m

Regis Resources has agreed to acquire a 30% interest in the Tropicana gold project in Western Australia firm Independence Group for $688.3m (A$903m) in cash.

Rio Tinto and Turquoise sign financing deal for Oyu Tolgoi expansion

Rio Tinto has signed an agreement with Turquoise Hill Resources on an updated financing plan for the $2.3bn underground development of the Oyu Tolgoi copper-gold mine in Mongolia.

CATL to acquire stake in DRC’s Kisanfu copper-cobalt mine in $137m deal

Battery maker Contemporary Amperex Technology (CATL) subsidiary Ningbo Brunp CATL New Energy will be acquiring a stake in the Kisanfu copper-cobalt mine in the Democratic Republic of Congo (DRC) for $137.5m.

Stantec plans to acquire mining project delivery consultant Engenium

Canada-based engineering firm Stantec has signed a letter of intent to purchase Engenium, an Australian mining project delivery and advisory services firm.

Rhizen signs oncology drug development deal with Curon

Swiss biopharma company Rhizen Pharmaceuticals has signed an exclusive licensing agreement with Curon Biopharmaceutical to develop and commercialise Tenalisib for oncology in the Greater China region. Tenalisib, a highly selective dual PI3K delta and gamma inhibitor, is currently in Phase II clinical development for haematological malignancies. The US FDA granted fast track and orphan drug designations for the drug candidate Tenalisib as a treatment for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.